Figure 2.
Enhanced expression of activation markers on TILs. A and B, Expression pattern of ICOS, CTLA-4, HLA-DR, and PD-1 on CD4 and CD8 TILs from 7 patients undergoing reductive surgery following ipilimumab treatment. Mean and SD are shown.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.